PDS Biotechnology Corporation (PDSB) — 分析师展望 / 分析师共识目标价为. 基于 7 位分析师评级, 共识为 看涨 — 6 买入, 1 持有.
分析师共识目标价为 $9.00, 上涨空间为 561.8% 相对于当前价格 $1.36.
分析师预估 每股收益(EPS)为 $-1.11 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1,079.45 vs 预期 $-1.11 (不及预期 -97147.7%). 2025: 实际 $-0.74 vs 预期 $-0.80 (超预期 +7.5%). 分析师准确度: 46%.
PDSB 股票 — 12个月价格预测
$9.00
▲ +561.76% 上涨空间
平均目标价
Based on 7 Wall Street analysts offering 12-month price targets for PDS Biotechnology Corporation, the price target is $9.00.
平均目标价相对最新价格 $1.36 变动 +561.76%。
PDSB 分析师评级
Buy
基于过去3个月内 7 位分析师对 PDS Biotechnology Corporation 的评级
EPS 预测 — PDSB
46%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1,079.45
vs Est –$1.11
▼ 99.9% off
2025
Actual –$0.74
vs Est –$0.80
▲ 8.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — PDSB
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
